Stock A009420 HANALL BIOPHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Hanall Biopharma Co., Ltd.

Equities

A009420

KR7009420001

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
37,600 KRW +1.76% Intraday chart for Hanall Biopharma Co., Ltd. +12.07% -15.12%
05-03 HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease CI
03-06 Hanall Biopharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Chart calendar Hanall Biopharma Co., Ltd.

145.gpcouCVP0U6XS5FFxqMYBwhg-ponhiH6gOK9xRHbI-s.yuRhyXo3o3egLc4cocFhbj5SruxKsnSwsKvnjHWXFLTl43LzczWkP-YMpQ~820b2bd5ea6aaef59cfcb0bb95ef767f

Upcoming events on Hanall Biopharma Co., Ltd.

13/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
06/04/2025 Q4 2024 Earnings Release (Projected)
29/04/2025 Q1 2025 Earnings Release (Projected)

Past events on Hanall Biopharma Co., Ltd.

30/04/2024 12:00 Q1 2024 Earnings Release
21/03/2024 11:00 Q4 2023 Earnings Release
07/01/2024 JPMorgan Healthcare Conference
06/01/2024 Sachs Associates Neuroscience Innovation Forum
26/10/2023 12:00 Q3 2023 Earnings Release
27/07/2023 12:00 Q2 2023 Earnings Release
28/04/2023 12:00 Q1 2023 Earnings Release
01/02/2023 12:00 FY 2022 Earnings Release
13/11/2022 Q3 2022 Earnings Release
15/08/2022 Interim 2022 Earnings Release
20/01/2022 14:00 FY 2021 Sales and Revenue Release
26/10/2021 Q3 2021 Sales and Revenue Release
16/08/2021 Interim 2021 Earnings Release
29/07/2021 11:44 Interim 2021 Sales and Revenue Release
06/05/2021 09:00 Q1 2021 Earnings Release
18/01/2021 FY 2020 Earnings Release
29/03/2020 FY 2019 Earnings Release
13/11/2019 Q3 2019 Earnings Release
14/05/2019 Q1 2019 Earnings Release
12/08/2018 Interim 2018 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		108
109
-0.26%		88,6
103
-13.89%		102
102
-0.3%		110
110
0.09%		135
137
-1.23%
144

EBITDA
Billions KRW		Released
Forecast
Spread 		19,8
22,3
-11.27%		8,83
25,4
-65.24%		12,8
15,8
-18.84%		4,56
8,00
-43.02%		5,46
11,2
-51.05%
7,00

EBIT
Billions KRW		Released
Forecast
Spread 		17,1
16,9
1.36%		5,94
14,4
-58.69%		10,1
11,9
-15.13%		1,51
5,20
-71.04%		2,21
7,63
-71.03%
3,60

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		17,5
18,5
-5.82%		19,6
22,4
-12.43%		8,70
13,3
-34.57%		1,93
5,00
-61.42%		3,20
9,13
-64.94%
5,86

Net income
Billions KRW		Released
Forecast
Spread 		19,2
16,7
15.05%		19,8
22,0
-10.16%		10,00
14,6
-31.51%		1,99
5,50
-63.85%		3,51
7,13
-50.81%
2,60

EPS
KRW		Released
Forecast
Spread 		375
318
17.8%		386
418
-7.66%		174
279
-37.63%		5,00
106
-95.28%		69,0
138
-49.96%
52,0

Announcement Date16/01/2019/01/2118/01/2219/01/2324/01/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Billions KRW		Released
Forecast
Spread 		24,9
25,9
-3.92%		24,0
24,9
-3.67%		26,2
32,8
-19.97%		29,6
29,6
0.14%		30,1
30,1
0.05%		28,8
37,8
-23.8%		41,4
31,1
33.28%		33,0
33,1
-0.24%		31,7
36,0
-11.89%		34,1



34,4


37,5


35,9

EBITDA
Billions KRW		Released
Forecast
Spread

















8,59
2,00
329.43%		0,67
1,20
-43.94%
-0,10













EBIT
Billions KRW		Released
Forecast
Spread 		0,92
2,60
-64.45%		-0,59
1,20
-149.33%		0,68
6,80
-89.98%		0,62
0,60
3.64%		0,79
4,50
-82.35%		-1,74
10,8
-116.1%		8,00
2,33
242.73%		0,10
1,05
-90.48%		-4,26
5,00
-185.27%



0,40


1,40


1,80

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,30
3,90
-92.18%		-0,01
1,20
-101.24%		0,58
6,50
-91.09%		0,73
0,70
4.91%		0,63
4,80
-86.86%


8,20
0,00
- 		0,51
0,20
155.39%














Net income
Billions KRW		Released
Forecast
Spread 		-0,95
3,80
-125.01%		-0,08
1,40
-105.93%		-0,08
5,80
-101.33%		0,73
0,70
4.91%		-0,32
4,90
-106.59%		-1,25
8,60
-114.58%		7,31
0,90
711.83%		0,30
1,08
-72.09%		-2,86
3,00
-195.44%		-0,30



0,60


1,30


1,60

Announcement Date18/01/2228/04/2216/08/2229/11/2219/01/2315/05/2326/07/2326/10/2324/01/2430/04/24---

Upcoming sector events for Hanall Biopharma Co., Ltd.

21/05/2024 GLAND PHARMA LIMITED: Q4 2024 Earnings Release
22/05/2024 SHILPA MEDICARE LIMITED: Q4 2024 Earnings Release
22/05/2024 ORCHID PHARMA LIMITED: Q4 2024 Earnings Release
23/05/2024 TORRENT PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
23/05/2024 SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED: Q4 2024 Earnings Release
24/05/2024 BLUE JET HEALTHCARE LIMITED: Q4 2024 Earnings Release
24/05/2024 AUROBINDO PHARMA: Q4 2024 Earnings Release
24/05/2024 DIVI'S LABORATORIES LIMITED: Q4 2024 Earnings Release
26/05/2024 CSPC PHARMACEUTICAL GROUP LTD.: Q1 2024 Earnings Release
26/05/2024 NATCO PHARMA LIMITED: Q4 2024 Earnings Release
More events

Past sector events for Hanall Biopharma Co., Ltd.

Today ERIS LIFESCIENCES LIMITED: Q4 2024 Earnings Release
20/05/2024 22:00 TARO PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release
17/05/2024 13:52 J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
17/05/2024 09:28 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
15/05/2024 15:05 MANKIND PHARMA LIMITED: Q4 2024 Earnings Release
15/05/2024 06:30 DERMAPHARM HOLDING SE: Q1 2024 Earnings Release
15/05/2024 12:40 CRESCO LABS INC.: Q1 2024 Earnings Release
15/05/2024 08:03 GRANULES INDIA LIMITED: Q4 2024 Earnings Release
14/05/2024 EISAI CO., LTD.: Q4 2023 Earnings Release
14/05/2024 22:43 LIQUIDIA CORPORATION: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A009420 Stock
  4. Calendar Hanall Biopharma Co., Ltd.